InvestorsHub Logo
Followers 44
Posts 864
Boards Moderated 0
Alias Born 03/08/2014

Re: manibiotech post# 280504

Wednesday, 04/29/2020 11:06:57 PM

Wednesday, April 29, 2020 11:06:57 PM

Post# of 700564
Like a number of PhDs who have foregone research/work in their specialty industry for the greener pastures of the investment community, Rago is, plain and simple, an analyst. He may have more credibility due to his academic credentials and prior work history and accordingly, he may have a decided edge in understanding the science and whether it is valid and promising. Accordingly, he is paid by Bigger just like any analyst is paid by an investment institution.

My feeling is that Rago evaluated NWBO/science and told Bigger.....look no guarantees but this looks promising. I would recommend it. Rago ain't stupid. He is compensated in part by the calls he makes. He is not going to knowingly recommend a dog. He is being paid to keep an eye on NWBO. As a professional credentialed analyst, he is not going to knowingly write up fluff to protect Bigger's (and his) investment. If he finds something amiss, like perhaps Duffy may have, he is going to cut his loses short. The general retail holder may not know it until too late but he be gone like Chuck Berry's air-mobile. If you don't hear from him/Bigger, that's a hint.

Bottom line, it is a good bet that Rago really believes in NWBO and writes accordingly in favor of his thesis because that's where his facts and perspectives lead him. JMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News